Scarica l'app Stockscreener
9.02
3.09%
0.27
Dopo l'orario di chiusura:
9.17
0.15
+1.66%
Precedente Chiudi:
$8.75
Aprire:
$8.66
Volume 24 ore:
836.02K
Relative Volume:
1.55
Capitalizzazione di mercato:
$487.91M
Reddito:
$2.81M
Utile/perdita netta:
$-97.34M
Rapporto P/E:
-5.7089
EPS:
-1.58
Flusso di cassa netto:
$-91.47M
1 W Prestazione:
-6.53%
1M Prestazione:
-2.17%
6M Prestazione:
+60.50%
1 anno Prestazione:
+181.00%
Intervallo 1D:
$8.48
$9.47
Intervallo di 1 settimana:
$8.29
$10.11
Portata 52W:
$2.315
$10.11
Fulcrum Therapeutics Inc Stock (FULC) Company Profile
Nome
Fulcrum Therapeutics Inc
Settore
Industria
Telefono
617-651-8851
Indirizzo
26 LANDSDOWNE STREET, CAMBRIDGE, MA
Confronta FULC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
FULC
Fulcrum Therapeutics Inc
|
9.02 | 473.30M | 2.81M | -97.34M | -91.47M | -1.58 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Fulcrum Therapeutics Inc Stock (FULC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-29 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2025-05-23 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2025-05-15 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2024-09-13 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2024-09-12 | Downgrade | BofA Securities | Neutral → Underperform |
| 2024-09-12 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2024-09-12 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-09-12 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-09-12 | Downgrade | Stifel | Buy → Hold |
| 2024-09-09 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2024-05-20 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-03-13 | Iniziato | RBC Capital Mkts | Outperform |
| 2023-09-25 | Iniziato | Goldman | Neutral |
| 2023-08-23 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2023-08-22 | Aggiornamento | Stifel | Hold → Buy |
| 2023-05-04 | Downgrade | Goldman | Buy → Neutral |
| 2023-03-10 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2023-03-10 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2023-03-09 | Downgrade | Stifel | Buy → Hold |
| 2023-02-28 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2023-02-24 | Downgrade | BofA Securities | Neutral → Underperform |
| 2022-11-15 | Iniziato | Goldman | Buy |
| 2022-03-08 | Iniziato | Oppenheimer | Outperform |
| 2022-03-03 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2021-08-11 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2021-04-26 | Ripresa | Credit Suisse | Outperform |
| 2021-03-22 | Iniziato | Credit Suisse | Outperform |
| 2021-03-02 | Iniziato | Stifel | Buy |
| 2020-10-16 | Iniziato | Piper Sandler | Overweight |
| 2020-08-12 | Downgrade | BofA Securities | Neutral → Underperform |
| 2020-08-12 | Reiterato | H.C. Wainwright | Buy |
| 2020-08-12 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-06-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2020-06-17 | Iniziato | BTIG Research | Buy |
| 2019-10-03 | Iniziato | H.C. Wainwright | Buy |
| 2019-08-12 | Iniziato | BofA/Merrill | Buy |
Mostra tutto
Fulcrum Therapeutics Inc Borsa (FULC) Ultime notizie
Will Fulcrum Therapeutics Inc. stock beat EPS estimatesTrade Risk Summary & Safe Entry Momentum Tips - newser.com
Can Fulcrum Therapeutics Inc. stock resist sector downturns2025 Trading Recap & Technical Entry and Exit Alerts - newser.com
Will Fulcrum Therapeutics Inc. stock gain from strong economyJuly 2025 Price Swings & Reliable Breakout Stock Forecasts - newser.com
Multi asset correlation models including Fulcrum Therapeutics Inc.July 2025 Weekly Recap & Advanced Swing Trade Entry Plans - newser.com
How Fulcrum Therapeutics Inc. stock responds to policy changesWeekly Risk Report & Capital Efficiency Focused Strategies - newser.com
What is Leerink Partnrs' Estimate for FULC FY2025 Earnings? - MarketBeat
FY2025 EPS Forecast for Fulcrum Therapeutics Cut by Analyst - MarketBeat
FY2025 EPS Estimate for Fulcrum Therapeutics Cut by Analyst - MarketBeat
Why Fulcrum Therapeutics Inc. stock is in analyst buy zone2025 Short Interest & Fast Gaining Stock Reports - newser.com
Fulcrum Therapeutics Inc. stock outlook for YEAR2025 Macro Impact & Short-Term High Return Strategies - newser.com
Will Fulcrum Therapeutics Inc. continue its uptrendPortfolio Value Summary & High Accuracy Trade Signal Alerts - newser.com
Published on: 2025-11-02 22:53:39 - newser.com
Signal strength of Fulcrum Therapeutics Inc. stock in tech scannersJuly 2025 Decliners & Fast Entry Momentum Alerts - newser.com
Fulcrum Therapeutics Inc. stock volume spike explainedMarket Risk Summary & Capital Protection Trade Alerts - newser.com
What risks investors should watch in Fulcrum Therapeutics Inc. stockMarket Trend Report & Fast Momentum Stock Entry Tips - newser.com
Tick level data insight on Fulcrum Therapeutics Inc. volatilityMarket Movement Recap & Technical Entry and Exit Tips - newser.com
Fulcrum Therapeutics (NASDAQ:FULC) Stock Rating Lowered by Wall Street Zen - MarketBeat
Statistical indicators supporting Fulcrum Therapeutics Inc.’s strengthSell Signal & Free Weekly Chart Analysis and Trade Guides - newser.com
How to track smart money flows in Fulcrum Therapeutics Inc.Market Activity Report & Reliable Volume Spike Alerts - newser.com
What is HC Wainwright's Estimate for FULC Q1 Earnings? - MarketBeat
How institutional buying supports Fulcrum Therapeutics Inc. stockJuly 2025 Earnings & Fast Entry and Exit Trade Plans - newser.com
Fulcrum Therapeutics (NASDAQ:FULC) Price Target Raised to $7.00 - MarketBeat
Published on: 2025-10-31 05:47:11 - newser.com
Is Fulcrum Therapeutics Inc. trending in predictive chart modelsBreakout Watch & High Return Trade Guides - newser.com
How sustainable is Fulcrum Therapeutics Inc. stock dividend payoutMarket Volume Report & Accurate Intraday Trade Tips - newser.com
How to forecast Fulcrum Therapeutics Inc. trends using time series - newser.com
Momentum divergence signals in Fulcrum Therapeutics Inc. chart2025 Institutional Moves & Accurate Entry/Exit Alerts - newser.com
Fulcrum Therapeutics Inc (FULC) Q3 2025 Earnings Call Highlights: Promising Advances in Sickle ... By GuruFocus - Investing.com Canada
Fulcrum Therapeutics Inc (FULC) Q3 2025 Earnings Call Highlights - GuruFocus
Fulcrum Therapeutics (FULC) Price Target Increased by 10.32% to 12.46 - MSN
RBC Capital Updates Fulcrum Therapeutics (FULC) Price Target Ami - GuruFocus
Fulcrum Therapeutics (NASDAQ:FULC) Releases Quarterly Earnings Results, Misses Estimates By $0.02 EPS - MarketBeat
Piper Sandler Raises Price Target on Fulcrum Therapeutics (FULC) - GuruFocus
Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Q3 2025 Earnings Call Transcript - Insider Monkey
Fulcrum Therapeutics (NASDAQ:FULC) Sets New 1-Year HighShould You Buy? - MarketBeat
Fulcrum Therapeutics Q3 2025 Earnings Call Transcript - MarketBeat
Fulcrum Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
Fulcrum Therapeutics Inc Azioni (FULC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.64%
0.35%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):